Provided by Tiger Fintech (Singapore) Pte. Ltd.

CorMedix Inc.

11.62
+0.03000.26%
Post-market: 11.50-0.1200-1.03%16:49 EDT
Volume:1.08M
Turnover:12.40M
Market Cap:864.87M
PE:41.86
High:11.73
Open:11.63
Low:11.34
Close:11.59
Loading ...

CorMedix Initiated at Outperform by Leerink Partners

Dow Jones
·
07 Mar

BUZZ-CorMedix gains after Leerink starts coverage with 'outperform'

Reuters
·
07 Mar

Leerink Partners Initiates CorMedix at Outperform With $18 Price Target

MT Newswires Live
·
07 Mar

CorMedix Inc expected to post earnings of 13 cents a share - Earnings Preview

Reuters
·
07 Mar

CorMedix Inc : Leerink Partners Initiates Coverage With Outperform Rating; Price Target $18

THOMSON REUTERS
·
07 Mar

Optimistic Buy Rating for Cormedix Driven by DefenCath’s Market Potential and Strategic Growth

TIPRANKS
·
07 Mar

CorMedix Is Maintained at Buy by D. Boral Capital

Dow Jones
·
05 Mar

Loss-Making CorMedix Inc. (NASDAQ:CRMD) Set To Breakeven

Simply Wall St.
·
04 Mar

BRIEF-Elliott Investment Management L.P. Cuts Share Stake In Southwest Airlines, Dissolves In Cardinal Health

Reuters
·
15 Feb

We're Hopeful That CorMedix (NASDAQ:CRMD) Will Use Its Cash Wisely

Simply Wall St.
·
22 Jan

BRIEF-Cormedix Announces Collaboration For Defencath Promotion

Reuters
·
21 Jan

CorMedix announces collaboration with WSI PBG for DefenCath

TIPRANKS
·
21 Jan

CorMedix Announces Collaboration for Defencath Promotion to the Va and Other Federal Facilities

THOMSON REUTERS
·
21 Jan

CorMedix Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities

GlobeNewswire
·
21 Jan

Here's Why We're Not Too Worried About CorMedix's (NASDAQ:CRMD) Cash Burn Situation

Simply Wall St.
·
17 Jan

CorMedix initiated with a Buy at D. Boral Capital

TIPRANKS
·
13 Jan

RBC Capital Keeps Their Buy Rating on Cormedix (CRMD)

TIPRANKS
·
10 Jan

Stock Track | CorMedix Inc. Stock Soars 5% as Analyst Reiterates Buy Rating

Stock Track
·
08 Jan

Cormedix (CRMD) Receives a Buy from Truist Financial

TIPRANKS
·
08 Jan

CorMedix Shares Rise 21% After Preliminary 4Q Results Beat Estimates

Dow Jones
·
07 Jan